501 related articles for article (PubMed ID: 19406247)
1. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
Jamal W; Shahin M; Rotimi VO
Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data.
Jamal W; Al Hashem G; Rotimi VO
Anaerobe; 2015 Feb; 31():25-30. PubMed ID: 25193745
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
5. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
8. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
[TBL] [Abstract][Full Text] [Related]
10. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
[TBL] [Abstract][Full Text] [Related]
11. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Houhoula DP; Legakis NJ; Tsakris A; Avlamis A
J Antimicrob Chemother; 2008 Jul; 62(1):137-41. PubMed ID: 18385145
[TBL] [Abstract][Full Text] [Related]
13. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic sensitivity of anaerobic bacteria isolated during one year (1993)].
Durán MT; Molina F
Enferm Infecc Microbiol Clin; 1996; 14(6):370-6. PubMed ID: 8756216
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
Behra-Miellet J; Dubreuil L; Calvet L
Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of blood culture isolates of anaerobic bacteria at a Norwegian university hospital.
Kommedal O; Nystad TW; Bølstad B; Digranes A
APMIS; 2007 Aug; 115(8):956-61. PubMed ID: 17696952
[TBL] [Abstract][Full Text] [Related]
19. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Snydman DR; Jacobus NV; McDermott LA
Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
